Skip to content

Two doses of perioperative dexamethasone further reduced early postoperative nausea and vomiting than single dose dexamethasone: A randomized blinded placebo-controlled trial

Two doses of perioperative dexamethasone further reduced early postoperative nausea and vomiting than single dose dexamethasone: A randomized blinded placebo-controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088512
Enrollment
Unknown
Registered
2024-08-20
Start date
2021-06-03
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Interventions

A:two doses of normal saline
B:a single dose of 10 mg dexamethasone before surgery and normal saline after surgery
C:two doses of 5 mg dexamethasone during the perioperative period

Sponsors

Shanghai Changzheng Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients between the ages of 18 and 75 years with a diagnosis of knee osteoarthritis who were scheduled for elective unilateral primary total knee arthroplasty

Exclusion criteria

Exclusion criteria: 1. History of hormone use within one month before surgery 2. Use of strong opioids within 7 days before surgery 3, the patient has rheumatic immune system diseases (like wind, gout, ankylosing spondylitis, etc.) 4. Patients with liver and kidney failure 5. A history of drug abuse 6. Diabetic patients 7. Patients with gastrointestinal diseases (chronic gastritis, gastric ulcer, etc.) 8. Patients with greater risk of postoperative infection 9. Patients with any history of drug allergy

Design outcomes

Primary

MeasureTime frame
Incidences and severity of PONV within 24 h after surgery;The number and consumption of patients requiring morphine and metoclopramine;AS scores for nausea and vomiting at 2, 4, 6, and 24 h after surgery;Incidences of surgical site infection (SSI) as well as gastrointestinal bleeding (GIB) within 45 days after operation;

Secondary

MeasureTime frame
Blood glucose levels on days 1, 2, and 3 after operation;

Countries

China

Contacts

Public ContactFu Peiliang

Shanghai Changzheng Hospital

fupeiliang@163.com+86 136 3637 7845

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026